A study to assess real-world outcomes of Direct Oral Anticoagulants in pediatric patients for treatment of an acute VTE episode or prevention of thrombosis recurrence
Latest Information Update: 04 Jan 2021
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Enoxaparin sodium (Primary) ; Heparin (Primary) ; Rivaroxaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms ATHN-15
- 04 Jan 2021 New trial record
- 08 Dec 2020 Interim results (n=76; as of 31 May 2020) presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology